BACKGROUND: Integrating mobile phone technologies in addiction treatment is of increasing importance and may optimize patient engagement with their care and enhance the delivery of existing treatment strategies. Few studies have evaluated mobile phone and text message (TM) use patterns in persons enrolled in addiction treatment, and none have assessed the use in safety net, office-based buprenorphine practices. METHODS: A 28-item, quantitative and qualitative semistructured survey was administered to opiate-dependent adults in an urban, publicly funded, office-based buprenorphine program. Survey domains included demographic characteristics, mobile phone and TM use patterns, and preferences pertaining to their recovery. RESULTS: Surveyors approached 73 of the 155 eligible subjects (47%); 71 respondents completed the survey. Nearly all participants reported mobile phone ownership (93%) and TM use (93%), and most reported "very much" or "somewhat" comfort sending TM (79%). Text message contact with 12-step group sponsors, friends, family members, and counselors was also described (32%). Nearly all preferred having their providers' mobile phone number (94%), and alerting the clinic via TM in the event of a potential relapse to receive both supportive TM and a phone call from their buprenorphine provider was also well received (62%). CONCLUSIONS: Mobile phone and TM use patterns and preferences among this sample of office-based buprenorphine participants highlight the potential of adopting patient-centered mobile phone-based interventions in this treatment setting.
BACKGROUND: Integrating mobile phone technologies in addiction treatment is of increasing importance and may optimize patient engagement with their care and enhance the delivery of existing treatment strategies. Few studies have evaluated mobile phone and text message (TM) use patterns in persons enrolled in addiction treatment, and none have assessed the use in safety net, office-based buprenorphine practices. METHODS: A 28-item, quantitative and qualitative semistructured survey was administered to opiate-dependent adults in an urban, publicly funded, office-based buprenorphine program. Survey domains included demographic characteristics, mobile phone and TM use patterns, and preferences pertaining to their recovery. RESULTS: Surveyors approached 73 of the 155 eligible subjects (47%); 71 respondents completed the survey. Nearly all participants reported mobile phone ownership (93%) and TM use (93%), and most reported "very much" or "somewhat" comfort sending TM (79%). Text message contact with 12-step group sponsors, friends, family members, and counselors was also described (32%). Nearly all preferred having their providers' mobile phone number (94%), and alerting the clinic via TM in the event of a potential relapse to receive both supportive TM and a phone call from their buprenorphine provider was also well received (62%). CONCLUSIONS: Mobile phone and TM use patterns and preferences among this sample of office-based buprenorphineparticipants highlight the potential of adopting patient-centered mobile phone-based interventions in this treatment setting.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: David H Gustafson; Bret R Shaw; Andrew Isham; Timothy Baker; Michael G Boyle; Michael Levy Journal: Subst Use Misuse Date: 2011 Impact factor: 2.164
Authors: Caroline Free; Rosemary Knight; Steven Robertson; Robyn Whittaker; Phil Edwards; Weiwei Zhou; Anthony Rodgers; John Cairns; Michael G Kenward; Ian Roberts Journal: Lancet Date: 2011-07-02 Impact factor: 79.321
Authors: Babak Tofighi; Noelle Leonard; Peter Greco; Aboozar Hadavand; Michelle C Acosta; Joshua D Lee Journal: J Addict Med Date: 2019 Jul/Aug Impact factor: 3.702
Authors: Brent A Moore; Frank D Buono; Destiny M B Printz; Daniel P Lloyd; David A Fiellin; Christopher J Cutter; Richard S Schottenfeld; Declan T Barry Journal: Exp Clin Psychopharmacol Date: 2017-12 Impact factor: 3.157
Authors: Margo E Godersky; Jared W Klein; Joseph O Merrill; Kendra L Blalock; Andrew J Saxon; Jeffrey H Samet; Judith I Tsui Journal: J Addict Med Date: 2020 Jul/Aug Impact factor: 3.702